Maluba, Salasina M.

HRN: 28-46-04  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/25/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/25/2026
02/01/2026
IV
4.5g
Q8h
Sepsis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines